Atlas Trials

A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection

Clinical trial NCT04144855 · UNKNOWN

Trial details

NCT number
NCT04144855
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumor
Start date
2018-11-27
Primary completion
2020-11-27
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.